NIDA has committed $2 million in fiscal year (FY) 2014 to fund two to three awards for scientists who propose cutting-edge—and possibly transformative—approaches to major challenges in biomedical and behavioral research on HIV/AIDS that are relevant to drug abuse. Applications are due November 6, 2013. For more information, see RFA-DA-14-008
The National Institute on Drug Abuse (NIDA) intends to commit $4 million to fund 8 to 10 awards in fiscal year 2012 to support implementation science projects that will inform the President’s Emergency Program for AIDS Relief (PEPFAR) as it develops more efficient and cost-effective methods to deliver HIV prevention, treatment, and care for drug-using populations.
Two NIDA-supported meetings featured international drug abuse research during the XVIII International AIDS Conference, which was held July 18–23, in Vienna, Austria. Prevention and Treatment of HIV and AIDS Among Drug-Using Populations: A Global Perspective was chaired by NIDA AIDS Research Program Director Dr. Jacques Normand and featured presentations by NIDA Director Dr. Nora Volkow on the neurobiology of drug use and HIV risk behavior; U.S. Global AIDS Coordinator Dr.
Mr. Hasan Aamoudi (left), chair, and Dr. Mohammed F. Al-Afifi, director of the Palestinian Substance Abuse Research Center, accept the UNAIDS Red Ribbon Award from Ms. Emily Blitz, International AIDS Society.
Kenneth W. Griffin, Ph.D., M.P.H., Weill Cornell Medical College, and Irina Pervova, Ph.D., St. Petersburg State University (SPSU), used Dr. Griffin’s U.S. Distinguished International Scientist Collaboration Award (USDISCA) to conduct key informant interviews and focus groups on the epidemiology, etiology, and prevention activities regarding adolescent substance use in St.
As part of his research into preventing HIV and hepatitis C infections among injection drug users, Pedro Mateu-Gelabert, Ph.D., National Development and Research Institutes, noticed that drug dealers in New York were creating heroin brands by labeling the glassine envelopes in which they distributed the drug. Working with the Social Art Collective in New York City, Dr.
The governments of Tanzania and the United States have announced that the first medication- assisted therapy (MAT) program for drug users in sub-Saharan Africa will begin shortly at two sites in Dar es Salaam and one in Zanzibar. Recognizing that high-risk practices related to drug use contribute to HIV transmission, the Tanzania Drug Control Commission (DCC) has promoted and adopted novel and evidence-based interventions to facilitate improved access to services that prevent HIV among drug users.
In research funded by NIDA and the Fogarty International Center (FIC), Jasmin Vassileva, Ph.D., University of Chicago, is investigating the impact of heroin on neurocognitive function and HIV transmission in Bulgaria. Why Bulgaria? In Chicago, up to 80% of heroin users also use cocaine, making it difficult to isolate the effects of a single drug. In contrast, Bulgarian heroin users are more likely to use only that drug. In addition, both heroin addiction and HIV are major public health problems and research is scarce in the country where Dr. Vassileva was born. Dr.